Neuropeptide Y and norepinephrine are localized in sympathetic nerve terminals throughout the heart. We sought to determine the functional distribution of the neuropeptide Y-containing sympathetic fibers to the sinus and atrioventricular (AV) nodal regions. We recorded cycle length, AV interval, and arterial pressure in 14 anesthetized dogs. We assessed the release of neuropeptide Y from sympathetic nerve terminals by measuring the attenuation of the vagal effects on cycle length and AV interval that occurred after unilateral ansa subclavia stimulation. Three-minute trains of right or left ansa stimulation, each applied at frequencies of 2, 5, and 10 Hz, produced a frequency-dependent inhibition of the vagal effects on cycle length and AV interval. After right ansa stimulation (10 Hz), however, the percent inhibition of the vagal effects on cycle length was 21±5% greater (p<0.001) than the percent inhibition of the vagal effects on AV interval. Conversely, after left ansa stimulation (10 Hz), the percent inhibition of the vagal effects on AV interval was 54±7% greater (p<O0.001) than the percent inhibition of the vagal effects on cycle length. The vagal stimulus characteristics (frequency or voltage) did not significantly alter the percent inhibition, nor did the percent inhibition depend on the vagus stimulated (right or left vagus). We conclude that most of the neuropeptide Y-containing sympathetic fibers at the sinus node originate in right-sided ganglia, whereas most of those at the AV node originate in left-sided ganglia. (Circulation Research 1990;67:713-721) T he sympathetic nervous system richly innervates the myocardium and modulates various aspects of cardiac function. Received February 15, 1990; accepted May 7, 1990. sity of large vesicles within the sympathetic neurons that -innervate a tissue or a specific region of a tissue.12-'4 Moreover, although NPY and norepinephrine are released together on sympathetic activation,9 15-18 the ratio of NPY to norepinephrine release increases as the sympathetic stimulation frequency is augmented.17 This frequency-dependent release may be related to the separate storage sites of NPY and norepinephrine within the nerve terminal.13'17
Neuropeptide Y and norepinephrine are localized in sympathetic nerve terminals throughout the heart. We sought to determine the functional distribution of the neuropeptide Y-containing sympathetic fibers to the sinus and atrioventricular (AV) nodal regions. We recorded cycle length, AV interval, and arterial pressure in 14 anesthetized dogs. We assessed the release of neuropeptide Y from sympathetic nerve terminals by measuring the attenuation of the vagal effects on cycle length and AV interval that occurred after unilateral ansa subclavia stimulation. Three-minute trains of right or left ansa stimulation, each applied at frequencies of 2, 5, and 10 Hz, produced a frequency-dependent inhibition of the vagal effects on cycle length and AV interval. After right ansa stimulation (10 Hz), however, the percent inhibition of the vagal effects on cycle length was 21±5% greater (p<0.001) than the percent inhibition of the vagal effects on AV interval. Conversely, after left ansa stimulation (10 Hz), the percent inhibition of the vagal effects on AV interval was 54±7% greater (p<O0.001) than the percent inhibition of the vagal effects on cycle length. The vagal stimulus characteristics (frequency or voltage) did not significantly alter the percent inhibition, nor did the percent inhibition depend on the vagus stimulated (right or left vagus). We conclude that most of the neuropeptide Y-containing sympathetic fibers at the sinus node originate in right-sided ganglia, whereas most of those at the AV node originate in left-sided ganglia. (Circulation Research 1990;67:713-721)
T he sympathetic nervous system richly innervates the myocardium and modulates various aspects of cardiac function.1-3 Most cardiac regions receive postganglionic sympathetic fibers that originate bilaterally in the stellate and caudal cervical ganglia.1"2,4-6 Some cardiac regions, however, are innervated predominantly by postganglionic sympathetic neurons that originate in either right or left sympathetic ganglia. [4] [5] [6] [7] [8] This asymmetry of cardiac sympathetic innervation has been substantiated functionally and anatomically. [4] [5] [6] [7] [8] In addition to containing stores of norepinephrine, postganglionic sympathetic neurons are now known to contain abundant stores of neuropeptide Y (NPY).9-"1 Within the sympathetic nerve endings, most of the NPY is stored in large vesicles, whereas the norepinephrine is stored in both large and small vesicles.12 13The amount of NPY released on sympathetic activation, therefore, may depend on the den-sity of large vesicles within the sympathetic neurons that -innervate a tissue or a specific region of a tissue.12-'4 Moreover, although NPY and norepinephrine are released together on sympathetic activation,9 [15] [16] [17] [18] the ratio of NPY to norepinephrine release increases as the sympathetic stimulation frequency is augmented.17 This frequency-dependent release may be related to the separate storage sites of NPY and norepinephrine within the nerve terminal.13 '17 In various tissues, NPY attenuates the release of norepinephrine and acetylcholine from sympathetic and parasympathetic nerve terminals, respectively.918-2' In the heart, NPY persistently inhibits the effects of vagal stimulation on cardiac. cycle length and atrioventricular (AV) nodal conduction. [22] [23] [24] Although the cardiac distribution of norepinephrine-containing sympathetic neurons has been examined extensively, '-8 The chest was opened transversely at the fourth intercostal space. The right and left stellate ganglia were isolated, doubly ligated, and transected. We looped bipolar stimulating electrodes (Harvard Apparatus, South Natick, Mass.) under the right and left ansae subclaviae. We sutured bipolar electrodes to the right atrium and right ventricle to record atrial and ventricular electrograms, respectively. A second bipolar electrode was sutured to the right atrial appendage for atrial pacing.
We continuously recorded the arterial blood pressure, the atrial and ventricular electrograms, the AA interval, and the AV interval on an oscillograph (model ES1000, Gould). We used the AA interval as a measure of the cardiac cycle length and the AV interval as a measure of AV conduction time. The AA and AV intervals were determined from the electrograms by an analog interval meter that was accurate to within 1 msec. The wires from the right and left ansa subclavia electrodes and the right and left cervical vagi electrodes were attached to individual stimulators (model S9, Grass Instruments, Quincy, Mass.).
Sympathetic Stimulation Protocol
The ansae subclaviae were stimulated supramaximally (7-10 V, 1-msec pulse width) either unilaterally or bilaterally, as required by protocol. We applied the sympathetic stimulation for a train duration of 3 minutes at frequencies of 2, 5, and 10 Hz.
Vagal Stimulation Protocols
We used two different vagal stimulation protocols ("unilateral" and "bilateral") to determine the functional distribution of NPY-containing sympathetic fibers to the sinus and AV nodes (Figure 1 To determine whether the effect of ansa stimulation on the cardiac responses to unilateral vagal stimulation depended on which vagus we stimulated, we also used a bilateral vagal stimulation protocol (Figure 1 ). With the bilateral vagal stimulation protocol, we tested the effects of stimulating each vagus nerve on cycle length and on AV interval. We could then determine if the cardiac responses to right and left vagal stimulation were affected disparately by the ansa stimulation.
Unilateral Vagal Stimulation Protocol
Before right or left ansa stimulation, we adjusted the frequency of right vagal stimulation to increase the cardiac cycle length by about 100%, and we adjusted the frequency of left vagal stimulation to prolong the AV interval substantially without losing 1:1 AV conduction. The vagi were stimulated supramaximally (1.4-2.8 V, 1-msec pulse width) for a train duration of 15 seconds. The stimuli were applied alternately to the right and left vagi every other minute. This stimulation technique produced stable cardiac responses in the present and previous studies.2324 We measured the vagal effects on AV interval only during atrial pacing at a constant frequency. We paced the right atrium at a cycle length 30-90 msec shorter than the prevailing spontaneous cycle length. The effects of vagal stimulation on cycle length and AV interval were measured before and after 3-minute trains of unilateral right and left ansa stimulation (2, 5, and 10 Hz). The six trains of ansa stimulation were applied in a random order in each dog (n=5).
Bilateral Vagal Stimulation Protocol
Before ansa stimulation, we adjusted the frequencies of right and left vagal stimulation to evoke similar increases in either cycle length or AV interval ( Figure  1 , Table 1 ). the effects of sequential right and left ansa stimulation, each at 5 and 10 Hz, on the vagally induced increases in cycle length and AV interval. Because we examined separately the AV interval and cycle length responses, a total of eight ansa stimulations were applied in random order in each dog (n=4).
Effects of Vagal Stimulation Frequency and Voltage
In the unilateral and bilateral stimulation protocols, we used a wide range of vagal stimulation frequencies to evoke increases in cycle length and AV interval (e.g., see Table 1 ). We designed the following protocol to determine whether the percentage inhibition of the cardiac vagal effects induced by ansa stimulation depended on the characteristics of the vagal stimulation. We evoked increases in cycle length by applying a stimulation train containing nine different frequency-voltage combinations to the right vagus. We applied vagal stimulation frequencies of 2, 4, and 8 Hz, each at stimulation voltages of 0.8+0.1, 1.2+0.1, and 2.0+0.2 V (mean±SEM, n=5). We labeled the vagal stimulation voltages as low, medium, and high. The high vagal stimulation voltage was supramaximal. The medium and low voltages were adjusted to evoke vagally induced cardiac responses that were approximately 66% and 33%, respectively, of the cardiac responses evoked with the high stimulation voltage. The nine frequency-voltage combinations were applied consecutively in random sequence to the vagus, each for a train duration of 
Results
Unilateral Stimulation Experiments Figure 2 shows representative examples of the cardiac responses to our unilateral vagal stimulation protocol. In this set of experiments, we measured the effects of right or left ansa stimulation on the cycle length responses to right vagal stimulation and on the AV interval responses to left vagal stimulation. During the control period in this representative experiment (Figure 2A ), we first stimulated the left vagus for 15 seconds during atrial pacing. The left vagal stimulation increased the AV interval to 161 msec from a control value of 104 msec. Approximately 15 seconds after the termination of left vagal stimulation, we interrupted the atrial pacing and allowed the heart to beat spontaneously. We then stimulated the right vagus for 15 seconds. In response to right vagal stimulation (Figure 2A ), the cycle length increased to 1,200 msec from a control value of 570 msec. After we completed the control vagal stimulations, we applied a 3-minute train of stimulation to the right ansa subclavia at a frequency of 10 Hz (Figure 2A ). The cycle length decreased to 320 msec during stimulation.
After the termination of right ansa stimulation, we applied the same vagal stimulations ( Figure 2B ) that we had used previously (Figure 2A ). Three minutes after right ansa stimulation, right vagal stimulation increased the cardiac cycle length to only 760 msec from a control value of 520 msec, and left vagal stimulation (during atrial pacing) increased the AV interval to 145 msec from a control value of 102 msec. Thus, 3 minutes after the cessation of right ansa stimulation, the vagal effects on cycle length and AV interval were inhibited by 62% and 25%, respectively. We continued to stimulate the vagi every other minute until the vagally induced cardiac responses returned to their control levels (data not shown). (Figure 2D ), the vagal effects on cycle length were inhibited by only 6%, whereas the vagal effects on AV interval were inhibited by 73%. Figure 3 shows representative time courses of the recovery of vagally induced cycle length and AV interval responses obtained after the cessation of 3-minute trains of right ( Figure 3A ) and left ( Figure  3B) Figure  3B ). The magnitude and duration of the attenuation of vagal effects at the sinus and AV nodes differed depending on whether the right or left ansa had been stimulated. After right ansa stimulation, the magnitude and duration of the inhibition of the vagal effects on cycle length was substantially greater than the magnitude and duration of the inhibition of the vagal effects on AV interval ( Figure 3A ). The converse was true after the termination of left ansa stimulation ( Figure 3B ).
To quantitate the inhibition of the vagal effects on the cardiac responses that occurred after ansa stimulation, we calculated the initial and summated inhibitions. We defined the initial inhibition as the attenuation of the first vagally induced response after the cessation of ansa stimulation. The initial inhibition was calculated as lOO(Rc-Re)/Rc, where R, is the control vagally induced response and R, is the first "experimental" response to vagal stimulation that we obtained after the cessation of ansa stimulation. We defined the summated inhibition as the area between a given recovery curve and the dashed horizontal line that represents the control value (100%) of the vagally induced response (see Figure  3) . This area, which we determined by integration, represents the inhibitory effect of right or left ansa stimulation summated over the full duration of the response. (Figures 2-4) . Although the inhibitory effects evoked by left ansa stimulation were predominant at the AV node, they also prevailed at the sinus node. Similarly, although the inhibitory effects elicited by right ansa stimulation were predominant at the sinus node, they were also manifest at the AV node. Bilateral Stimulation Experiments Figure S shows representative cycle length responses to our bilateral vagal stimulation protocol. During the control period ( Figure 5A ), right vagal stimulation increased the cycle length to 1,160 msec from a control value of 580 msec. One minute later, we stimulated the left vagus at a frequency that also increased the cycle length to 1,160 msec. We then stimulated the left ansa at a frequency of 10 Hz for 3 minutes ( Figure 5A ). Three minutes after left ansa stimulation ( Figure 5B length were not appreciably different from the control responses ( Figure 5A ). In contrast, 3 minutes after right ansa stimulation ( Figure SD) , the effects of right and left vagal stimulation on cycle length were substantially attenuated. We continued to stimulate the vagi every other minute until the vagally induced cycle length responses returned to their control levels (data not shown).
We also examined AV interval responses to the bilateral vagal stimulation protocol. Figure 6 shows representative time courses of the recovery of the right and left vagal effects on cycle length ( Figure  6A ) and AV interval ( Figure 6B ) after the termination of ansa stimulation (10 Hz) . The magnitude and duration of the inhibition of the vagal effects on cycle length evoked by right ansa stimulation were substantially greater than those evoked by left ansa stimulation ( Figure 6A) . Conversely, the inhibition of the vagal effects on the AV interval evoked by left ansa stimulation was much greater than that evoked by right ansa stimulation ( Figure 6B) . Note, however, that after each ansa stimulation, the time course of the inhibition of the right vagal effects was similar to that of the left vagal effects on either cycle length ( Figure 6A ) or AV interval ( Figure 6B ). Figure 8 shows representative examples of the chronotropic responses to nine different vagal stimulation frequency-voltage combinations applied before and after bilateral ansa subclavia stimulation. During the control period ( Figure 8A ), vagal stimulation increased the cardiac cycle length by 95-1,300 msec above control; the increment depended on the frequency-voltage combination.
Effects of Vagal Stimulation Characteristics
After we elicited the control responses, we stimulated the ansae subclaviae at a frequency of 10 Hz for 3 minutes. Three minutes after the cessation of ansae stimulation ( Figure 8B ), the cycle length responses to the vagal stimulation combinations were inhibited by 36-46%. The vagal effects on cycle length returned gradually to control. At 15 minutes after sympathetic stimulation, the vagal effects were inhibited by 9-27% ( Figure 8D ). Figure 9 summarizes (n=5) the percent inhibitions of the vagally induced chronotropic responses at 6-minute intervals after the cessation of ansae stimulation. At any given time after ansae stimulation, the chronotropic responses evoked by the nine different vagal stimulation combinations were attenuated by a similar percent (p>0.55). Thus, changes in either the vagal stimulation voltage or frequency did significantly alter the percent inhibition of the vagal effects on cycle length after the termination of sympathetic stimulation. inhibition of the vagal effects depended on whether the right or left ansa subclavia had been stimulated. Indeed, after right ansa stimulation, the vagal effects on cardiac cycle length were significantly more attenuated than were the vagal effects on AV interval. Conversely, after left ansa stimulation, the AV inter- the majority of such fibers to the AV node originated in left-sided ganglia. The sinus node did, however, receive some NPY-containing sympathetic fibers that originated on the left side, whereas the AV node was innervated by some such fibers that originated on the right side. Thus, both nodal regions were bilaterally innervated by NPY-containing sympathetic fibers, but the distributions were asymmetrical. The asymmetry in the functional distribution of these sympathetic fibers to the sinus and AV nodes parallels that of sympathetic fibers that contain norepinephrine.
These functional data also agree with immunohistochemical data that show that cardiac NPYimmunoreactive and norepinephrine-containing neurons have similar distributions and densities. 10'11 We used unilateral and bilateral vagal stimulation protocols to determine the functional distribution of NPY-containing sympathetic fibers. The results of these experiments showed that right or left ansa subclavia stimulation attenuated the effects of vagal stimulation on cycle length and AV interval disparately. By examining the cycle length and AV interval responses in each unilateral vagal stimulation protocol, we found that the inhibition of vagal effects at the sinus node was substantially different from that at the AV node after right or left ansa stimulation (Figures 2-4) . The bilateral vagal stimulation experiments demonstrated that the disparate effects of ansa stimulation at the sinus and AV nodes were independent of the vagus stimulated (Figures 5-7) . Thus, in the bilateral stimulation experiments we found that, after ansa stimulation, the inhibition of right vagal effects was similar in magnitude and duration to the inhibition of left vagal effects. These data support our hypothesis that most NPY-containing sympathetic fibers to the sinus node originate in right-sided ganglia, whereas most of those fibers to the AV node originate in left-sided ganglia.
Our data also show that the percent inhibition of the cardiac vagal effects after ansa stimulation did not depend on the frequency or voltage of the vagal stimulus (Figures 8 and 9) The persistent attenuation of vagal effectiveness after sympathetic activation has been attributed to the release of NPY from sympathetic nerve terminals.20,22-24 The attenuation of the vagal effects evoked by sympathetic stimulation remains after combined aand /3-adrenergic receptor blockade, and it is mimicked by exogenous NPY, but not by exogenous norepinephrine.22-24 NPY appears to inhibit cardiac vagal effects by diminishing the release of acetylcholine from vagal nerve terminals.'9-21 Indeed, Potter20 showed in anesthetized dogs that the increases in cardiac cycle length evoked by bethanechol, a muscarinic agonist, were not substantially affected by exogenous NPY, whereas the increases in cycle length evoked by vagal stimulation were persistently inhibited. Although these results suggest strongly that NPY released from sympathetic nerve terminals inhibits cardiac vagal effects, we cannot exclude the possibility that other mechanisms may also play a role. NPY antagonists would enhance our ability to fully characterize the role of NPY in neural control of the heart and to determine whether NPY alone mediates the persistent inhibition of vagally induced cardiac responses that occurs after sympathetic activation.
